UK earnings, trading statements calendar - next 7 days
18th Feb 2026 16:37
| Price | 575.00p on 20-02-2026 at 19:25:08 |
|---|---|
| Change | -5.00p -0.86% |
| Buy | 580.00p |
| Sell | 570.00p |
| Last Trade: | Unknown 7,498.00 at 563.00p |
| Day's Volume: | 33,151 |
| Last Close: | 575.00p |
| Open: | 580.00p |
| ISIN: | GB0009188797 |
| Day's Range | 575.00p - 580.00p |
| 52wk Range: | 304.00p - 607.50p |
| Market Capitalisation: | £191.30m |
| VWAP: | 571.02616p |
| Shares in Issue: | 33.27m |
Sector: Industrial Engineering
Listed In: FTSE AIM All-Share,
Avingtrans (AVG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 7,498 | 563.00p | Negotiated Trade |
16:38:20 - 20-Feb-26 |
| Unknown* | 10,935 | 575.00p | Negotiated Trade |
16:08:03 - 20-Feb-26 |
| Sell* | 1,200 | 570.50p | Ordinary |
16:07:57 - 20-Feb-26 |
| Unknown* | 513 | 575.00p | Ordinary |
16:02:01 - 20-Feb-26 |
| Sell* | 150 | 570.00p | Ordinary |
15:58:26 - 20-Feb-26 |
| Sell* | 67 | 570.00p | Ordinary |
15:33:26 - 20-Feb-26 |
| Buy* | 3 | 580.00p | Ordinary |
15:01:32 - 20-Feb-26 |
| Unknown* | 0 | 580.00p | SI Trade |
15:01:32 - 20-Feb-26 |
| Buy* | 1 | 580.00p | SI Trade |
15:01:32 - 20-Feb-26 |
| Unknown* | 0 | 580.00p | SI Trade |
15:01:32 - 20-Feb-26 |
Avingtrans (AVG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Feb 2026 11:49 am | RNS | Holding(s) in Company |
| 6th Feb 2026 10:24 am | RNS | Holding(s) in Company |
| 27th Jan 2026 5:42 pm | RNS | Exercise of Options & TVR |
| 21st Jan 2026 7:00 am | RNS | Trading Update and Notice of Results |
| 12th Jan 2026 5:13 pm | RNS | Issue of Share Options |
| 12th Jan 2026 7:00 am | RNS-R | Medical & Industrial Imaging Division Appointment |
| 8th Dec 2025 2:34 pm | RNS | Notification of Major Holdings |
| 27th Nov 2025 1:59 pm | RNS | Result of AGM - Board Appointment |
| 14th Nov 2025 8:38 am | RNS | Exercise of Options & PDMR Dealings |
| 10th Nov 2025 7:00 am | RNS | Adaptix receives FDA 510(K) clearance |